These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 29037960)

  • 21. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis.
    Tang H; Huang T; Jing J; Shen H; Cui W
    Infection; 2009 Dec; 37(6):497-507. PubMed ID: 19826761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections.
    Li H; Luo YF; Blackwell TS; Xie CM
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5900-6. PubMed ID: 21947386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed antibiotics for symptoms and complications of respiratory infections.
    Spurling GK; Del Mar CB; Dooley L; Foxlee R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004417. PubMed ID: 15495108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
    Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
    Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
    Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
    BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Antibiotic Discontinuation Strategies on Mortality and Infectious Complications in Critically Ill Septic Patients: A Meta-Analysis and Trial Sequential Analysis.
    Arulkumaran N; Khpal M; Tam K; Baheerathan A; Corredor C; Singer M
    Crit Care Med; 2020 May; 48(5):757-764. PubMed ID: 32191414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection.
    Huang DT; Yealy DM; Filbin MR; Brown AM; Chang CH; Doi Y; Donnino MW; Fine J; Fine MJ; Fischer MA; Holst JM; Hou PC; Kellum JA; Khan F; Kurz MC; Lotfipour S; LoVecchio F; Peck-Palmer OM; Pike F; Prunty H; Sherwin RL; Southerland L; Terndrup T; Weissfeld LA; Yabes J; Angus DC;
    N Engl J Med; 2018 Jul; 379(3):236-249. PubMed ID: 29781385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin Testing to Guide Antibiotic Therapy in Acute Upper and Lower Respiratory Tract Infections.
    Schuetz P; Wirz Y; Mueller B
    JAMA; 2018 Mar; 319(9):925-926. PubMed ID: 29509850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial.
    Do NT; Ta NT; Tran NT; Than HM; Vu BT; Hoang LB; van Doorn HR; Vu DT; Cals JW; Chandna A; Lubell Y; Nadjm B; Thwaites G; Wolbers M; Nguyen KV; Wertheim HF
    Lancet Glob Health; 2016 Sep; 4(9):e633-41. PubMed ID: 27495137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
    Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P
    Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
    van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
    Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Procalcitonin-guided Antibiotics in Respiratory Infections (PARI) project in general practice - a study protocol.
    Filipsen N; Bro H; Bjerrum L; Jensen JS; Aabenhus R
    BMC Prim Care; 2022 Mar; 23(1):43. PubMed ID: 35279069
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.